Aytu Biopharma, Inc. (AYTU)
2.57
-0.09
(-3.38%)
USD |
NASDAQ |
Apr 07, 16:00
2.60
+0.03
(+1.17%)
After-Hours: 20:00
Aytu Biopharma Total Assets (Quarterly) : 122.00M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Altimmune, Inc. | 279.93M |
| Actinium Pharmaceuticals, Inc. | 52.21M |
| Aldeyra Therapeutics, Inc. | 72.06M |
| Annovis Bio, Inc. | 21.08M |
| BioAtla, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 107.80M |
| Shareholders Equity (Quarterly) | 14.20M |
| Debt to Equity Ratio | 1.556 |
| Current Ratio | 1.163 |
| Net Debt Paydown Yield | -2.81% |